Armata Pharmaceuticals (ARMP) Shares Outstanding (Diluted Average) (2016 - 2026)
Quarterly results put Shares Outstanding (Diluted Average) at $36.5 million for Q1 2026, down 38.58% from a year ago — trailing twelve months through Mar 2026 was $36.5 million (down 38.58% YoY), and the annual figure for FY2023 was $36.1 million, up 5.19%.
Armata Pharmaceuticals has reported Shares Outstanding (Diluted Average) over the past 14 years, most recently at $36.5 million for Q1 2026.
- Shares Outstanding (Diluted Average) reached $36.5 million in Q1 2026 per ARMP's latest filing, up from $36.2 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $59.5 million in Q1 2025 and bottomed at $29.0 million in Q1 2022.
- Median Shares Outstanding (Diluted Average) over the past 5 years was $36.1 million (2024), compared with a mean of $39.7 million.
- The largest annual shift saw Shares Outstanding (Diluted Average) surged 73.89% in 2023 before it tumbled 38.58% in 2026.
- Over 5 years, Shares Outstanding (Diluted Average) stood at $34.3 million in 2022, then grew by 5.19% to $36.1 million in 2023, then grew by 0.29% to $36.2 million in 2024, then grew by 0.06% to $36.2 million in 2025, then rose by 0.91% to $36.5 million in 2026.
- Business Quant data shows Shares Outstanding (Diluted Average) for ARMP at $36.5 million in Q1 2026, $36.2 million in Q3 2025, and $36.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 107.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 36.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.53 Mn |
| Sep 30, 2025 | 36.20 Mn |
| Jun 30, 2025 | 36.19 Mn |
| Mar 31, 2025 | 59.48 Mn |
| Sep 30, 2024 | 36.18 Mn |
| Jun 30, 2024 | 58.25 Mn |
| Mar 31, 2024 | 36.12 Mn |
| Dec 31, 2023 | 36.08 Mn |
| Sep 30, 2023 | 36.07 Mn |
| Jun 30, 2023 | 56.54 Mn |
| Mar 31, 2023 | 36.05 Mn |
| Dec 31, 2022 | 34.29 Mn |
| Sep 30, 2022 | 36.04 Mn |
| Jun 30, 2022 | 32.52 Mn |
| Mar 31, 2022 | 29.00 Mn |
| Dec 31, 2021 | 24.10 Mn |
| Sep 30, 2021 | 23.36 Mn |
| Jun 30, 2021 | 22.62 Mn |
| Mar 31, 2021 | 20.46 Mn |
| Dec 31, 2020 | 16.42 Mn |
| Sep 30, 2020 | 15.74 Mn |
| Jun 30, 2020 | 14.40 Mn |
| Dec 31, 2019 | 8.01 Mn |
| Sep 30, 2019 | 7.50 Mn |
| Jun 30, 2019 | 7.72 Mn |
| Dec 31, 2018 | 4.65 Mn |
| Sep 30, 2018 | 4.65 Mn |
| Jun 30, 2018 | 4.65 Mn |
| Dec 31, 2017 | 6.57 Mn |
| Sep 30, 2017 | 5.52 Mn |
| Jun 30, 2017 | 5.52 Mn |
| Dec 31, 2016 | 983,846.00 |
| Sep 30, 2016 | 864,891.00 |
| Jun 30, 2016 | 876,806.00 |